BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16020482)

  • 1. DARPP-32 (dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal phosphoprotein) is essential for the maintenance of thyroid differentiation.
    García-Jiménez C; Zaballos MA; Santisteban P
    Mol Endocrinol; 2005 Dec; 19(12):3060-72. PubMed ID: 16020482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A.
    Tsygankova OM; Saavedra A; Rebhun JF; Quilliam LA; Meinkoth JL
    Mol Cell Biol; 2001 Mar; 21(6):1921-9. PubMed ID: 11238928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DARPP-32 is required for MAPK/ERK signaling in thyroid cells.
    Chocarro-Calvo A; Zaballos MA; Santisteban P; García-Jiménez C
    Mol Endocrinol; 2012 Mar; 26(3):471-80. PubMed ID: 22301787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras inhibits thyroglobulin expression but not cyclic adenosine monophosphate-mediated signaling in Wistar rat thyrocytes.
    Kupperman E; Wofford D; Wen W; Meinkoth JL
    Endocrinology; 1996 Jan; 137(1):96-104. PubMed ID: 8536648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ephedrine induced thioredoxin-1 expression through β-adrenergic receptor/cyclic AMP/protein kinase A/dopamine- and cyclic AMP-regulated phosphoprotein signaling pathway.
    Jia JJ; Zeng XS; Li Y; Ma S; Bai J
    Cell Signal; 2013 May; 25(5):1194-201. PubMed ID: 23416460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal negative regulation between thyrotropin/3',5'-cyclic adenosine monophosphate-mediated proliferation and caveolin-1 expression in human and murine thyrocytes.
    Costa MJ; Senou M; Van Rode F; Ruf J; Capello M; Dequanter D; Lothaire P; Dessy C; Dumont JE; Many MC; Van Sande J
    Mol Endocrinol; 2007 Apr; 21(4):921-32. PubMed ID: 17202321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of c-ras reactivates thyroglobulin synthesis in middle-T transformed thyroid cells.
    Di Jeso B; Feliciello A; Pacifico F; Iannelli A; D'Armiento F; Liguoro D; Giuliano P; Ferulano G; Avvedimento EV
    Cell Growth Differ; 1995 Oct; 6(10):1315-9. PubMed ID: 8845309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p66Shc expression in proliferating thyroid cells is regulated by thyrotropin receptor signaling.
    Park YJ; Kim TY; Lee SH; Kim H; Kim SW; Shong M; Yoon YK; Cho BY; Park DJ
    Endocrinology; 2005 May; 146(5):2473-80. PubMed ID: 15705774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells.
    Saji M; Akamizu T; Sanchez M; Obici S; Avvedimento E; Gottesman ME; Kohn LD
    Endocrinology; 1992 Jan; 130(1):520-33. PubMed ID: 1309347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3',5'-monophosphate signal action.
    Saji M; Kohn LD
    Endocrinology; 1991 Feb; 128(2):1136-43. PubMed ID: 1846578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Transcription Factor NF-κB Mediates Thyrotropin-Stimulated Expression of Thyroid Differentiation Markers.
    Geysels RC; Peyret V; Martín M; Nazar M; Reale C; Bernal Barquero CE; Miranda L; Martí MA; Vito P; Masini-Repiso AM; Nicola JP
    Thyroid; 2021 Feb; 31(2):299-314. PubMed ID: 32935630
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells.
    Dremier S; Milenkovic M; Blancquaert S; Dumont JE; Døskeland SO; Maenhaut C; Roger PP
    Endocrinology; 2007 Oct; 148(10):4612-22. PubMed ID: 17584967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation expression during proliferative activity induced through different pathways: in situ hybridization study of thyroglobulin gene expression in thyroid epithelial cells.
    Pohl V; Roger PP; Christophe D; Pattyn G; Vassart G; Dumont JE
    J Cell Biol; 1990 Aug; 111(2):663-72. PubMed ID: 2199463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesis.
    Uyttersprot N; Allgeier A; Baptist M; Christophe D; Coppee F; Coulonval K; Deleu S; Depoortere F; Dremier S; Lamy F; Ledent C; Maenhaut C; Miot F; Panneels V; Parma J; Parmentier M; Pirson I; Pohl V; Roger P; Savonet V; Taton M; Tonacchera M; van Sande J; Wilkin F; Vassart G
    Adv Second Messenger Phosphoprotein Res; 1997; 31():125-40. PubMed ID: 9344247
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles.
    Kraiem Z; Sadeh O; Yosef M; Aharon A
    Endocrinology; 1995 Feb; 136(2):585-90. PubMed ID: 7835292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility class I gene transcription in thyrocytes: a series of interacting regulatory DNA sequence elements mediate thyrotropin/cyclic adenosine 3',5'-monophosphate repression.
    Kirshner S; Palmer L; Bodor J; Saji M; Kohn LD; Singer DS
    Mol Endocrinol; 2000 Jan; 14(1):82-98. PubMed ID: 10628749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.
    Martelli ML; Trapasso F; Bruni P; Berlingieri MT; Battaglia C; Vento MT; Belletti B; Iuliano R; Santoro M; Viglietto G; Fusco A
    Exp Cell Res; 1998 Nov; 245(1):195-202. PubMed ID: 9828116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective modulation of protein kinase A I and II reveals distinct roles in thyroid cell gene expression and growth.
    Calebiro D; de Filippis T; Lucchi S; Martinez F; Porazzi P; Trivellato R; Locati M; Beck-Peccoz P; Persani L
    Mol Endocrinol; 2006 Dec; 20(12):3196-211. PubMed ID: 16887886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ha-ras interference with thyroid cell differentiation is associated with a down-regulation of thyroid transcription factor-1 phosphorylation.
    Velasco JA; Acebrón A; Zannini M; Martín-Pérez J; Di Lauro R; Santisteban P
    Endocrinology; 1998 Jun; 139(6):2796-802. PubMed ID: 9607786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA activation promotes transformation and loss of thyroid cell differentiation interfering with thyroid transcription factor-1 activity.
    Medina DL; Rivas M; Cruz P; Barroso I; Regadera J; Santisteban P
    Mol Endocrinol; 2002 Jan; 16(1):33-44. PubMed ID: 11773437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.